Literature DB >> 2462488

Divalent cations suppress 3',5'-adenosine monophosphate accumulation by stimulating a pertussis toxin-sensitive guanine nucleotide-binding protein in cultured bovine parathyroid cells.

C J Chen1, J V Barnett, D A Congo, E M Brown.   

Abstract

We used pertussis toxin to study the mechanism(s) by which divalent cations lower cellular cAMP content in bovine parathyroid cells. In cultured parathyroid cells, high extracellular Ca2+ (5 mM) or Mg2+ (5-10 mM) lowers dopamine-stimulated cAMP content by 70-90%. Pertussis toxin (0.5 microgram/ml) totally blocks the inhibitory effects of Ca2+ and Mg2+ on cAMP content. Ba2+ and Sr2+ (5 mM) also lower cAMP content by 80-90%, and this effect is, likewise, blocked by pertussis toxin. Pretreatment with pertussis toxin had no effect on the release of cAMP into the extracellular fluid. The toxin also did not modify phosphodiesterase activity in sonicates of parathyroid cells (42.68 +/- 3.26 vs. 47.00 +/- 2.82 pmol cAMP hydrolyzed/10(6) cells.20 min in control and toxin-treated cells, respectively). Moreover, addition of the phosphodiesterase inhibitor isobutyl-methylxanthine did not modify the inhibition of dopamine-stimulated cAMP accumulation by 5 mM Ca2+ in control cells (85% vs. 86% inhibition, respectively, with and without isobutylmethylxanthine). Pertussis toxin-catalyzed ADP ribosylation in homogenates of control cells demonstrated the presence of two substrates with mol wt of 40K and 41K. Preexposure of cells to pertussis toxin overnight resulted in the complete loss of both substrates on subsequent ADP ribosylation with [32P]NAD. Pertussis toxin pretreatment did not enhance adenylate cyclase activity indirectly via reducing the extracellular Ca2+-induced rise in cytosolic Ca2+, since the cytosolic Ca2+ level at 5 mM Ca2+ was about 60% higher in pertussis toxin-treated than in control cells (531 +/- 85 vs. 326 +/- 35 nM; P less than 0.05). In addition, ionomycin had no significant effect on cellular cAMP levels in control cells despite increasing the cytosolic Ca2+ concentration to levels as high as 1700 nM at 10(-5) M. Thus, changes in cytosolic Ca2+ phosphodiesterase activity, or efflux of cAMP from the cell cannot explain the inhibition of cAMP accumulation by divalent cations or the reversal of this effect by pertussis toxin. Instead, the present data suggest that extracellular divalent cations modulate the formation of cellular cAMP in parathyroid cells by a process involving a pertussis toxin-sensitive guanine nucleotide regulatory protein, presumably inhibition of adenylate cyclase by Gi via a receptor-like mechanism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2462488     DOI: 10.1210/endo-124-1-233

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  22 in total

Review 1.  Is the calcium receptor a molecular target for the actions of strontium on bone?

Authors:  Edward M Brown
Journal:  Osteoporos Int       Date:  2003-03-12       Impact factor: 4.507

2.  Identification of a dopamine- and 3'5'-cyclic adenosine monophosphate-regulated phosphoprotein of 32 kD (DARPP-32) in parathyroid hormone-producing cells of the human parathyroid gland.

Authors:  B Meister; J Askergren; G Tunevall; H C Hemmings; P Greengard
Journal:  J Endocrinol Invest       Date:  1991-09       Impact factor: 4.256

Review 3.  Cellular physiology and pathophysiology of the parathyroid glands.

Authors:  G Akerström; J Rastad; S Ljunghall; P Ridefelt; C Juhlin; E Gylfe
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

Review 4.  Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders.

Authors:  K Leach; P M Sexton; A Christopoulos; A D Conigrave
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 5.  Calcium-sensing receptor 20 years later.

Authors:  Tariq I Alfadda; Ahmad M A Saleh; Pascal Houillier; John P Geibel
Journal:  Am J Physiol Cell Physiol       Date:  2014-05-28       Impact factor: 4.249

Review 6.  International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function.

Authors:  Katie Leach; Fadil M Hannan; Tracy M Josephs; Andrew N Keller; Thor C Møller; Donald T Ward; Enikö Kallay; Rebecca S Mason; Rajesh V Thakker; Daniela Riccardi; Arthur D Conigrave; Hans Bräuner-Osborne
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

7.  Juxtaglomerular cell CaSR stimulation decreases renin release via activation of the PLC/IP(3) pathway and the ryanodine receptor.

Authors:  M Cecilia Ortiz-Capisano; Mahendranath Reddy; Mariela Mendez; Jeffrey L Garvin; William H Beierwaltes
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-05

8.  Parathyroid-specific interaction of the calcium-sensing receptor and G alpha q.

Authors:  Min Pi; Ling Chen; MinZhao Huang; Qiang Luo; L Darryl Quarles
Journal:  Kidney Int       Date:  2008-08-27       Impact factor: 10.612

Review 9.  Thick ascending limb: the Na(+):K (+):2Cl (-) co-transporter, NKCC2, and the calcium-sensing receptor, CaSR.

Authors:  Gerardo Gamba; Peter A Friedman
Journal:  Pflugers Arch       Date:  2008-11-04       Impact factor: 3.657

10.  Cytosolic calcium homeostasis in bovine parathyroid cells and its modulation by protein kinase C.

Authors:  F K Racke; E F Nemeth
Journal:  J Physiol       Date:  1993-08       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.